Development of an Undiagnosed Mass Registry: Lessons Learned From Our First 100 Patients

Introduction: The Undiagnosed Mass Clinic (UMC) at our institution is a clinical and research program created to address gaps in the early diagnostic phase of the cancer care continuum for patients with potential malignant neoplasms. All patients referred to the UMC are invited to participate in the...

Full description

Saved in:
Bibliographic Details
Main Authors: Steven W. Ressler, Ivana T. Croghan, Marlene E. Girardo, John P. Fasolino, Elizabeth A. Gilman, Nate P. Erwin, Nancy L. Dawson, Joan M. Irizarry-Alvarado, Ryan T. Hurt, Karthik Ghosh
Format: Article
Language:English
Published: SAGE Publishing 2025-03-01
Series:Journal of Primary Care & Community Health
Online Access:https://doi.org/10.1177/21501319251325650
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850036207977758720
author Steven W. Ressler
Ivana T. Croghan
Marlene E. Girardo
John P. Fasolino
Elizabeth A. Gilman
Nate P. Erwin
Nancy L. Dawson
Joan M. Irizarry-Alvarado
Ryan T. Hurt
Karthik Ghosh
author_facet Steven W. Ressler
Ivana T. Croghan
Marlene E. Girardo
John P. Fasolino
Elizabeth A. Gilman
Nate P. Erwin
Nancy L. Dawson
Joan M. Irizarry-Alvarado
Ryan T. Hurt
Karthik Ghosh
author_sort Steven W. Ressler
collection DOAJ
description Introduction: The Undiagnosed Mass Clinic (UMC) at our institution is a clinical and research program created to address gaps in the early diagnostic phase of the cancer care continuum for patients with potential malignant neoplasms. All patients referred to the UMC are invited to participate in the UMC registry, which tracks operational and clinical metrics while maintaining a repository of blood and tissue specimens for future research. Methods: We conducted a retrospective cohort study of the first 100 patients enrolled in the UMC registry. We analyzed patient demographics, final diagnoses, and the time from initial consultation to final diagnosis. Results: Most participants were White (86%), non-Hispanic (93%), and married (72%). The mean (SD) age was 64 (13.9) years. The final diagnoses of the masses were categorized as malignant/neoplastic with malignant potential (n = 53), benign (n = 36), or requiring diagnostic surveillance (n = 10). The mean (SD) time from initial consultation to final diagnosis of malignant/neoplastic with malignant potential masses significantly improved from 37.4 (36.6) days for the first 50 participants to 17.3 (19.7) days for the next 50 participants ( P  = .006). Conclusions: These initial insights from the UMC registry will help direct future efforts to improve the care of patients with potential malignant neoplasms.
format Article
id doaj-art-16bfe84759da476d8c2b177d4df81e68
institution DOAJ
issn 2150-1327
language English
publishDate 2025-03-01
publisher SAGE Publishing
record_format Article
series Journal of Primary Care & Community Health
spelling doaj-art-16bfe84759da476d8c2b177d4df81e682025-08-20T02:57:14ZengSAGE PublishingJournal of Primary Care & Community Health2150-13272025-03-011610.1177/21501319251325650Development of an Undiagnosed Mass Registry: Lessons Learned From Our First 100 PatientsSteven W. Ressler0Ivana T. Croghan1Marlene E. Girardo2John P. Fasolino3Elizabeth A. Gilman4Nate P. Erwin5Nancy L. Dawson6Joan M. Irizarry-Alvarado7Ryan T. Hurt8Karthik Ghosh9Mayo Clinic, Scottsdale, AZ, USAMayo Clinic, Rochester, MN, USAMayo Clinic, Scottsdale, AZ, USAMayo Clinic, Scottsdale, AZ, USAMayo Clinic, Rochester, MN, USAMayo Clinic, Rochester, MN, USAMayo Clinic, Jacksonville, FL, USAMayo Clinic, Jacksonville, FL, USAMayo Clinic, Rochester, MN, USAMayo Clinic, Rochester, MN, USAIntroduction: The Undiagnosed Mass Clinic (UMC) at our institution is a clinical and research program created to address gaps in the early diagnostic phase of the cancer care continuum for patients with potential malignant neoplasms. All patients referred to the UMC are invited to participate in the UMC registry, which tracks operational and clinical metrics while maintaining a repository of blood and tissue specimens for future research. Methods: We conducted a retrospective cohort study of the first 100 patients enrolled in the UMC registry. We analyzed patient demographics, final diagnoses, and the time from initial consultation to final diagnosis. Results: Most participants were White (86%), non-Hispanic (93%), and married (72%). The mean (SD) age was 64 (13.9) years. The final diagnoses of the masses were categorized as malignant/neoplastic with malignant potential (n = 53), benign (n = 36), or requiring diagnostic surveillance (n = 10). The mean (SD) time from initial consultation to final diagnosis of malignant/neoplastic with malignant potential masses significantly improved from 37.4 (36.6) days for the first 50 participants to 17.3 (19.7) days for the next 50 participants ( P  = .006). Conclusions: These initial insights from the UMC registry will help direct future efforts to improve the care of patients with potential malignant neoplasms.https://doi.org/10.1177/21501319251325650
spellingShingle Steven W. Ressler
Ivana T. Croghan
Marlene E. Girardo
John P. Fasolino
Elizabeth A. Gilman
Nate P. Erwin
Nancy L. Dawson
Joan M. Irizarry-Alvarado
Ryan T. Hurt
Karthik Ghosh
Development of an Undiagnosed Mass Registry: Lessons Learned From Our First 100 Patients
Journal of Primary Care & Community Health
title Development of an Undiagnosed Mass Registry: Lessons Learned From Our First 100 Patients
title_full Development of an Undiagnosed Mass Registry: Lessons Learned From Our First 100 Patients
title_fullStr Development of an Undiagnosed Mass Registry: Lessons Learned From Our First 100 Patients
title_full_unstemmed Development of an Undiagnosed Mass Registry: Lessons Learned From Our First 100 Patients
title_short Development of an Undiagnosed Mass Registry: Lessons Learned From Our First 100 Patients
title_sort development of an undiagnosed mass registry lessons learned from our first 100 patients
url https://doi.org/10.1177/21501319251325650
work_keys_str_mv AT stevenwressler developmentofanundiagnosedmassregistrylessonslearnedfromourfirst100patients
AT ivanatcroghan developmentofanundiagnosedmassregistrylessonslearnedfromourfirst100patients
AT marleneegirardo developmentofanundiagnosedmassregistrylessonslearnedfromourfirst100patients
AT johnpfasolino developmentofanundiagnosedmassregistrylessonslearnedfromourfirst100patients
AT elizabethagilman developmentofanundiagnosedmassregistrylessonslearnedfromourfirst100patients
AT nateperwin developmentofanundiagnosedmassregistrylessonslearnedfromourfirst100patients
AT nancyldawson developmentofanundiagnosedmassregistrylessonslearnedfromourfirst100patients
AT joanmirizarryalvarado developmentofanundiagnosedmassregistrylessonslearnedfromourfirst100patients
AT ryanthurt developmentofanundiagnosedmassregistrylessonslearnedfromourfirst100patients
AT karthikghosh developmentofanundiagnosedmassregistrylessonslearnedfromourfirst100patients